Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Like bad traffic, surgery is something to be avoided if at all possible.
Read entire article.
Urine test could hold key to early cancer diagnosis
"The findings could help the detection of [pancreatic] cancer in people who have not yet started to show symptoms."
"It would enable patients to be diagnosed much earlier, leading to improved survival rates."
Read entire article.
FDA approves new pancreatic cancer drug
"Data show Afinitor delays tumor growth and reduces risk of disease progression in patients with advanced neuroendocrine tumors (NET) of pancreatic origin," the Swiss drugmaker said in a statement.
"This marks the first approval of a treatment for this patient population in the United States in nearly 30 years."
Read entire article.
See article in LA Times about Rolfe funded scientist, Kevin Roggin and his collaboration with Kevin White in The University of Chicago's Institute for Genomics and Systems Biology.
Read entire article.